| S7242 |
Erastin
|
Erastin is a ferroptosis activator by acting on mitochondrial VDAC, exhibiting selectivity for tumor cells bearing oncogenic RAS. Solutions are unstable and should be fresh-prepared.
|
-
Biochemical and Biophysical Research Communications, September 10, 2018, 1689-1695
-
PLoS One, May 12, 2016, e0154605
-
Oncology Letters, July 29, 2020, 57
|
|
| S3544 |
VBIT-4
|
VBIT-4 is a voltage-dependent anion channel (VDAC) oligomerization inhibitor that decreases mitochondrial DNA (mtDNA) release, type I interferon (IFN) signaling, neutrophil extracellular traps, and disease severity in a mouse model of systemic lupus erythematosus.
|
-
Cell Rep, 2025, 44(5):115605
-
Cell Rep, 2025, 44(6):115834
-
Aging Cell, 2025, 24(9):e70135
|
|
| S8936 |
VBIT-12
|
VBIT-12 is a potent inhibitor of Voltage-dependent anion-selective channel 1 (VDAC1), directly interacting with purified VDAC1, reducing its channel conductance and preventing VDAC1 oligomerization.
|
-
Journal of the American Heart Association, October 28, 2025, e045554T
-
Proceedings of the National Academy of Sciences, May 8, 2023, e2219644120
-
Environmental Pollution, February 15, 2022, 118720
|
|
| E5770 |
DIDS sodium salt
|
|
-
Integrative Cancer Therapies, 2019, 1534735418822120
|
|
| S0231 |
NSC15364
|
NSC 15364 (compound 59) is an inhibitor that directly interacts with VDAC1 and prevents VDAC1 oligomerization, concomitant with an inhibition of apoptosis.
|
-
Exp Cell Res, 2024, 434(2):113874
|
|